affect clinic trial start patient
recruit lower fve late-stag
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research
estim
price data
rate updat
currenc amount express
methodolog valu compani
pandem grip healthcar system
across globe expect continu delay clinic trial
challeng patient enrol second
quarter expect weigh backlog convers
iqvia icon health syneo health
adjust model account short-term impact
revenu difficulti trial monitor patient
recruit expect lower demand small
biotech client pullback fund like
riskier compani cost side model flat slightli
declin margin next two year result
fair valu
estim iqvia icon respect
low-double-digit percentag decreas health
syneo respect maintain
narrow moat rate contract research
organ base intang switch cost
think cover well equip
mitig impact much possibl implement
remot monitor pull forward virtual
work view sector overvalu earli
iqvia syneo health trade modest discount
fair valu market discount name
due higher leverag anticip
liquid concern even bear case iqvia end
year net leverag ratio time adjust ebitda
syneo priorit debt paydown
last two year end year ratio time
iqvia maintain billion debt princip
mostli due later balanc sheet
reinvest busi heavili repurchas
share addit market-lead cro busi
iqvia also earn roughli revenu technolog
analyt busi expect see minim
impact
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
iqvia result merger quintil lead global contract
research organ im health lead healthcar data
analyt provid cro segment focus primarili provid
outsourc late-stag clinic trial pharmaceut devic
technolog servic client healthcar industri includ
pharmaceut compani provid payer policymak
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
trial impact vari case-by-cas basi expect
mani already-enrol trial especi treat
sever diseas continu site virtual trial
monitor at-hom servic somewhat mitig
impact site closur lockdown measur howev
despit expect trial start delay
new patient recruit halt delay
next sever week compar previou estim
model revenu growth lower roughli
basi point assum roughli one third
cro revenu tie site monitor
revenu delay next week
also think like see diminish
fund emerg cash-burn biotech
impact pandem hit global
economi lower busi win
think somewhat off-set pent-up demand
trial delay client
expect larger client remain fundament stabl
pharma research develop
spend continu grow midsingl digit
overal model revenu growth
coverag remain low singl digit strong
recoveri
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
financi summari forecast
fiscal year end decemb
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
fiscal year end decemb
good sold
depreci amort report separ
impair charg report separ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
fiscal year end decemb
equival
net properti plant equip
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
